Table 4 Association between sociodemographics of diabetic patients and glycemic control.
Characteristics | Glycemic control, n (%) | N | p-value | |
|---|---|---|---|---|
Control | Uncontrolled | |||
Type 2 diabetes | 186 (47.9) | 202 (52.1) | 388 | |
Age (years) | ||||
< 40 | 9 (4.8) | 60 (29.7) | 69 | 0.711 |
40–60 | 154 (82.7) | 127 (62.8) | 281 | |
60–70 | 23 (12.3) | 15 (7.4) | 38 | |
Gender | ||||
Males | 81 (43.5) | 99 (49.0) | 180 | 0.12 |
Females | 105 (56.5) | 103 (51) | 208 | |
BMI (kg/m2) | ||||
Normal (18.5–24.9) | 19 (10.2) | 19 (9.4) | 38 | < 0.001* |
Overweight (25–30) | 86 (46.2) | 133 (50.9) | 219 | |
Obese (above 30) | 81 (43.5) | 50 (24.7) | 131 | |
Duration of treatment (years) | ||||
< 5 | 70 (37.6) | 105 (51.9) | 175 | 0.42 |
5–10 | 62 (33.3) | 89 (44.0) | 151 | |
> 10 | 27 (14.5) | 35 (17.3) | 62 | |
Type of anti-diabetic therapy | ||||
Monotherapy | 80 (43.0) | 55 (27.7) | 135 | < 0.05* |
Combination therapy | 106 (57.0) | 147 (72.7) | 253 | |
Anti-diabetic therapy | ||||
With lifestyle modifications | 156 (83.8) | 90 (44.5) | 246 | < 0.001* |
Without lifestyle modifications | 30 (16.2) | 112 (55.5) | 142 | |
